A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.
Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the odds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results